DFCM
APGE icon

Dark Forest Capital Management’s Apogee Therapeutics APGE Stock Holding History

Dark Forest Capital Management’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,476
Closed -$545K – 796
2026
Q1 		$545K Buy
+6,476
New +$470K 0.05% 533
2025
Q2 		– Sell
-29,871
Closed -$1.12M – 1169
2025
Q1 		$1.12M Buy
+29,871
New +$1.15M 0.05% 639
2024
Q4 		– Sell
-14,230
Closed -$836K – 926
2024
Q3 		$836K Buy
14,230
+147
+1% +$7.04K 0.11% 209
2024
Q2 		$554K Buy
14,083
+6,186
+78% +$300K 0.1% 241
2024
Q1 		$525K Buy
+7,897
New +$345K 0.09% 262

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dark Forest Capital Management's APGE Position: Q2 2026 in Review

Dark Forest Capital Management sold out of Apogee Therapeutics (APGE) in Q2 2026, closing a stake of 6,476 shares — an estimated $545K sold.

Dark Forest Capital Management first reported a position in APGE in Q1 2024 and held it in 5 quarters. The position peaked at $1.12M in Q1 2025. 288 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Dark Forest Capital Management reported no remaining Apogee Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 6,476 Apogee Therapeutics shares in Q2 2026, an estimated $545K.
  • Dark Forest Capital Management first reported a position in Apogee Therapeutics in Q1 2024 and held it in 5 quarters.
  • Dark Forest Capital Management's Apogee Therapeutics position peaked at $1.12M in Q1 2025.
  • 288 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.